Nurix therapeutics announces upcoming presentation of nx-5948 preclinical data at the eular 2021 virtual congress

Nx-5948, a potent selective degrader of btk, significantly reduces inflammation in a model of autoimmune disease nx-5948, a potent selective degrader of btk, significantly reduces inflammation in a model of autoimmune disease

NRIX Ratings Summary

NRIX Quant Ranking